Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Providers, Device Firms Disagree On ACO Fraud And Abuse Protections

This article was originally published in The Gray Sheet

Executive Summary

When it comes to waiving fraud and abuse laws for accountable care organizations, health care providers and device companies are on distinctly opposite sides of the fence.

You may also be interested in...



CMS Should Disclose Doc Incentive Payments Tied To Delivery Reforms, AdvaMed Says

Now that a federal court has lifted an injunction blocking CMS from releasing Medicare payment data linked to individual physicians, device firms see an opportunity for the agency to disclose payments doctors receive as incentives for participating in accountable care organizations and bundled payment initiatives. AdvaMed says the incentives could encourage physicians to stint on care.

Washington Roundup, June/July 2012

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we report on accountable care organizations and a new device adverse event smartphone app.

Accountable Care Organizations Proliferate Through Private, Government Payer Programs

Speaking at an ACO Summit June 7 in Washington, D.C., several CMS officials spoke of the power of partnership in driving growth in accountable care organizations.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030247

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel